- Contact Us
Diabetes affects more than 34 million people in the U.S., 90% to 95% of whom have Type 2 diabetes. As a chronic disease, uncontrolled diabetes can lead to serious health problems, such as diabetic nephropathy, vision impairment, podiatric complications, diabetic neuropathy, cardiovascular disease (CVD), stroke and more.
Research has shown that intensive glycemic control in patients with Type 2 diabetes decreases both the onset and progression of microvascular complications. Despite this increased understanding — including how intensive glycemic control can lead to decreased risk of myocardial infarction, microalbuminuria and coronary vascular disease — only 52% patients have their glycated hemoglobin (HbA1c) at or below the American Diabetes Association’s recommended level of 7%.
AANP has a number of resources available for nurse practitioners (NPs) who are treating patients with diabetes or prediabetes, including several tools to help patients make informed treatment decisions and maintain glycemic control. Check out AANP’s endocrinology resources to download one —or all four — of the patient education tools:
In addition, AANP has more than a dozen endocrinology-related continuing education (CE) activities — made available free for members — in the AANP CE Center, plus free access to evidence-based articles, up-to-date guidelines and other resources about endocrinology at the Journal of the American Association of Nurse Practitioners (JAANP) Resource Center.
In GLP-1 Receptor Agonists for Type 2 Diabetes: Incorporating the Latest Treatment Options Into Individualized Care, speakers Dixie Harms and Shannon Idzik, both NPs with expertise in diabetes care, discuss how to support patients in overcoming clinical inertia utilizing the 2020 American Diabetes Association (ADA) treatment algorithm. Three case studies will be presented to help NPs in clinical practice understand how and when to incorporate GLP-1 RAs into practice, set individualized therapeutic goals, achieve rapid attainment of HbA1c targets and help patients maintain glycemic control.
This 1.25-contact hour CE program, which includes 1.25 pharmacology credit, will be hosted on three occasions through the AANP CE Center as a webinar, with a live faculty question-and-answer (Q&A) period directly following each session. A synopsis of the live Q&A will be available once the program is launched in the AANP CE Center. Complete the activity to download an exclusive clinical resource tool for use in your practice!
The first live webinar will take place 11 a.m.–12:30 p.m. ET (10 a.m.–11:30 a.m. CT) on October 30, 2020. Register for free now to save your spot!